PRIMARY MALIGNANT-LYMPHOMA OF THE THYROID - A CLINICOPATHOLOGICAL ANALYSIS

被引:34
作者
LOGUE, JP [1 ]
HALE, RJ [1 ]
STEWART, AL [1 ]
DUTHIE, MB [1 ]
BANERJEE, SS [1 ]
机构
[1] CHRISTIE HOSP & HOLT RADIUM INST,DEPT HISTOPATHOL,MANCHESTER M20 9BX,LANCS,ENGLAND
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 1992年 / 22卷 / 05期
关键词
LYMPHOMA; THYROID; RADIOTHERAPY;
D O I
10.1016/0360-3016(92)90790-O
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A retrospective analysis of 70 patients with primary malignant lymphoma of the thyroid treated at this institute between 1965-1983 has been conducted. The clinicopathological features and prognostic factors have been studied. The mean age was 67.5 years and there was a marked female:male ratio of 8:1. A total of 32 (45.7%) Stage IE and 38 (54.3%) Stage IIE patients were identified. In 64 cases histological material was reviewed and classified employing the Kiel classification. All the tumors were of B cell lineage and the majority were follicle center cell type. A biopsy only was performed in 27 patients, lobectomy in 11 patients, subtotal thyroidectomy in 27 and macroscopic thyroidectomy in 5 patients. All patients were treated with radiotherapy. The overall 5-year survival was 42%, with 63% for Stage IE and 27% for Stage IIE. The corrected overall 5-year survival was 49% with 68% for Stage IE and 36% for Stage IIE. The corresponding overall relapse free survival was 42% with 60% for Stage IE, and 31% for Stage IIE. Factors of prognostic significance for relapse and survival were stage, radiotherapy dose, stridor, retrosternal extension and fixation.
引用
收藏
页码:929 / 933
页数:5
相关论文
共 10 条
[1]   PRIMARY MALIGNANT-LYMPHOMA OF THE THYROID - A TUMOR OF MUCOSA-ASSOCIATED LYMPHOID-TISSUE - REVIEW OF 76 CASES [J].
ANSCOMBE, AM ;
WRIGHT, DH .
HISTOPATHOLOGY, 1985, 9 (01) :81-97
[2]  
BANFI A, 1968, European Journal of Cancer, V4, P319, DOI 10.1016/0014-2964(68)90058-3
[3]   RADIOTHERAPEUTIC MANAGEMENT OF PRIMARY THYROID LYMPHOMA [J].
BLAIR, TJ ;
EVANS, RG ;
BUSKIRK, SJ ;
BANKS, PM ;
EARLE, JD .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1985, 11 (02) :365-370
[4]  
DEVINE RM, 1981, WORLD J SURG, V5, P233
[5]  
FREEMAN C, 1972, CANCER, V29, P252, DOI 10.1002/1097-0142(197201)29:1<252::AID-CNCR2820290138>3.0.CO
[6]  
2-#
[7]   LYMPHOMA OF THE THYROID [J].
HAMBURGER, JI ;
MILLER, JM ;
KINI, SR .
ANNALS OF INTERNAL MEDICINE, 1983, 99 (05) :685-693
[8]   MALIGNANT-LYMPHOMA OF THE THYROID-GLAND [J].
SOUHAMI, L ;
SIMPSON, WJ ;
CARRUTHERS, JS .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1980, 6 (09) :1143-1147
[9]   PRIMARY LYMPHOMA OF THE THYROID - CLINICAL-FEATURES, PROGNOSTIC FACTORS, AND RESULTS OF TREATMENT [J].
TUPCHONG, L ;
HUGHES, F ;
HARMER, CL .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1986, 12 (10) :1813-1821
[10]   THYROID LYMPHOMAS STAGE-IE AND STAGE-IIE COMPARATIVE RESULTS FOR RADIOTHERAPY ONLY, COMBINATION CHEMOTHERAPY ONLY, AND MULTIMODALITY TREATMENT [J].
VIGLIOTTI, A ;
KONG, JS ;
FULLER, LM ;
VELASQUEZ, WS .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1986, 12 (10) :1807-1812